A new drug improves the effectiveness of Tamiflu

A new drug improves the effectiveness of Tamiflu
E. DE B. - Madrid - 23/12/2009
 VoteResult No interésPoco interesanteDe interésMuy interesanteImprescindible 1 votesPrint Send
Toyama Japanese laboratory testing is finalizing a new drug that could end the dominance of Tamiflu as first line treatment against influenza. The product, which currently has code-named T-705, and has just completed phase I (safety) and II (efficacy) in Japan, and has begun to III (large scale), which is the last before submitting for marketing.

      The pandemic threat
      Influenza A
      DEPTH

      The pandemic threat

      Link full coverage
The news on other sites

    * Websites in Spanish
    * In other languages
The difference is that Tamiflu works on another cycle key proteins of influenza virus, the polymerase. This mechanism has the advantage that it is an internal process and vital to the virus (to the extent that one can say that a virus is alive), making it more difficult to have mutations. Also, do not give within 48 hours, so there is more room for maneuver. Fits all influenza viruses, including H5N1 and H1N1.